Explore more
News
FDA suspends muscular dystrophy drug
Digest more
India Today on MSN35m
Children's Hospital LA halts use of Sarepta's gene therapy for all patientsChildren's Hospital Los Angeles paused Sarepta's Elevidys gene therapy after FDA flagged safety issues, including deaths in ...
Earlier this week, we reported on a father of two children diagnosed with muscular dystrophy who has taken it upon himself to ...
As mothers of children with this disease, we have wept helplessly in recent months as friends — fellow members of a club we ...
As the controversy over the safety of Sarepta Therapeutics’ gene therapies comes to a head, the biotech is standing firm ...
The company refused the FDA’s request and will continue shipping its therapy, Elevidys, to Duchenne patients who can still ...
The crisis over Sarepta Therapeutics' Duchenne therapy offers a valuable lesson: Listening to critics, and responding with ...
The Sarepta saga continues, with the FDA slapping a clinical hold across all of the company’s investigational limb girdle ...
4hon MSN
After the FDA request, Cambridge, Massachusetts-based Sarepta said in a statement that it will continue to ship the therapy to ambulatory people but maintain a halt it implemented June 15 for ...
Children's Hospital Los Angeles, citing recent U.S. Food and Drug Administration actions, on Monday said it has paused usage of Sarepta Therapeutics' gene therapy Elevidys in all patients with ...
WTEN Albany on MSN3h
Local family raises over $5K for Muscular Dystrophy AssociationLocal family raises over $5K for Muscular Dystrophy Association ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback